Estrotone
Natural health product licensed in Canada
- Other names
- Menopause Take Care
- Licence holder
- New Chapter Inc
- NPN or DIN-HM
- 80009683
- Status
- Inactive licence
- Licence date
- 14 April 2009
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cimicifuga racemosa Source : Racine Extraction ratio : 4-9:1 Dry plant equivalent : 130 mg | 20 mg | Not calculated |
| Cimicifuga racemosa Source : Rhizome(s) Extraction ratio : 4-9:1 Dry plant equivalent : 130 mg | 20 mg | Not calculated |
| Vitex agnus-castus Source : Baie(s) Extraction ratio : 8:1 Dry plant equivalent : 160 mg | 20 mg | Not calculated |
| Schisandra chinensis Source : Baie(s) Extraction ratio : 11:1 Dry plant equivalent : 880 mg | 80 mg | Not calculated |
| Rosmarinus officinalis Source : Feuille(s) Extraction ratio : 26.5:1 Dry plant equivalent : 132.5 mg | 5 mg | Not calculated |
| Zingiber officinale Source : Rhizome(s) Extraction ratio : 14.5:1 Dry plant equivalent : 195.75 mg | 13.5 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Carob, Gélatine, huile d'olive, Cire d'abeille jaune, Maltodextrine, Glycérine végétale
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce symptoms associated with menopause. Promotes normal bone turnover in post-menopausal women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80009683
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.